These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 12193112

  • 1. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines.
    Usmani BA, Harden B, Maitland NJ, Turner AJ.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():314S-317S. PubMed ID: 12193112
    [Abstract] [Full Text] [Related]

  • 2. Expression and localization of endothelin-converting enzyme-1 in human prostate cancer.
    Dawson LA, Maitland NJ, Berry P, Turner AJ, Usmani BA.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1106-10. PubMed ID: 16741058
    [Abstract] [Full Text] [Related]

  • 3. Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression.
    Dawson LA, Maitland NJ, Turner AJ, Usmani BA.
    Br J Cancer; 2004 Apr 19; 90(8):1577-82. PubMed ID: 15083188
    [Abstract] [Full Text] [Related]

  • 4. Distribution of endothelin-converting enzyme-1 and neutral endopeptidase in human endometrium.
    Iwase A, Ando H, Nagasaka T, Goto M, Harata T, Kikkawa F.
    J Histochem Cytochem; 2007 Dec 19; 55(12):1229-35. PubMed ID: 17712175
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of neointima formation in an organ culture of human saphenous vein: a comparison of dual endothelin-converting enzyme/neutral endopeptidase and selective neutral endopeptidase inhibition.
    Porter KE, Dickinson T, London NJ.
    J Vasc Surg; 2001 Sep 19; 34(3):548-54. PubMed ID: 11533610
    [Abstract] [Full Text] [Related]

  • 6. ECE-1 influences prostate cancer cell invasion via ET-1-mediated FAK phosphorylation and ET-1-independent mechanisms.
    Whyteside AR, Hinsley EE, Lambert LA, McDermott PJ, Turner AJ.
    Can J Physiol Pharmacol; 2010 Aug 19; 88(8):850-4. PubMed ID: 20725143
    [Abstract] [Full Text] [Related]

  • 7. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis.
    Grantham JA, Schirger JA, Wennberg PW, Sandberg S, Heublein DM, Subkowski T, Burnett JC.
    Circulation; 2000 Apr 25; 101(16):1976-81. PubMed ID: 10779465
    [Abstract] [Full Text] [Related]

  • 8. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
    Hoang MV, Sansom CE, Turner AJ.
    Biochem J; 1997 Nov 01; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.
    Smollich M, Götte M, Yip GW, Yong ES, Kersting C, Fischgräbe J, Radke I, Kiesel L, Wülfing P.
    Breast Cancer Res Treat; 2007 Dec 01; 106(3):361-9. PubMed ID: 17295044
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The N-terminal segment of endothelin-converting enzyme (ECE)-1b contains a di-leucine motif that can redirect neprilysin to an intracellular compartment in Madin-Darby canine kidney (MDCK) cells.
    Cailler F, Zappulla JP, Boileau G, Crine P.
    Biochem J; 1999 Jul 01; 341 ( Pt 1)(Pt 1):119-26. PubMed ID: 10377252
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mapping the active site of endothelin-converting enzyme-1 through subsite specificity and mutagenesis studies: a comparison with neprilysin.
    Johnson GD, Swenson HR, Ramage R, Ahn K.
    Arch Biochem Biophys; 2002 Feb 15; 398(2):240-8. PubMed ID: 11831855
    [Abstract] [Full Text] [Related]

  • 17. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
    Kukkola PJ, Savage P, Sakane Y, Berry JC, Bilci NA, Ghai RD, Jeng AY.
    J Cardiovasc Pharmacol; 1995 Feb 15; 26 Suppl 3():S65-8. PubMed ID: 8587470
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.
    Wallace EM, Moliterni JA, Moskal MA, Neubert AD, Marcopulos N, Stamford LB, Trapani AJ, Savage P, Chou M, Jeng AY.
    J Med Chem; 1998 Apr 23; 41(9):1513-23. PubMed ID: 9554884
    [Abstract] [Full Text] [Related]

  • 20. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
    Sumitomo M, Shen R, Goldberg JS, Dai J, Navarro D, Nanus DM.
    Cancer Res; 2000 Dec 01; 60(23):6590-6. PubMed ID: 11118039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.